Clinical Trial Update: Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing two sequencing regimens for non-small cell lung cancer: docetaxel plus cisplatin followed by gemcitabine versus gemcitabine plus cispl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Platinol (cisplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED